TCRT icon

Alaunos Therapeutics

156 hedge funds and large institutions have $281M invested in Alaunos Therapeutics in 2020 Q4 according to their latest regulatory filings, with 27 funds opening new positions, 40 increasing their positions, 53 reducing their positions, and 25 closing their positions.

New
Increased
Maintained
Reduced
Closed

more funds holding

Funds holding:

more call options, than puts

Call options by funds: $ | Put options by funds: $

more first-time investments, than exits

New positions opened: | Existing positions closed:

more capital invested

Capital invested by funds: $ → $

0.01% more ownership

Funds ownership: 0.34%0.35% (+0.01%)

0% more funds holding in top 10

Funds holding in top 10: 22 (0)

25% less repeat investments, than reductions

Existing positions increased: 40 | Existing positions reduced: 53

Holders
156
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
2
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$2.72M
Puts
$2.51M
Net Calls
Net Calls Change

Top Buyers

1 +$9.01M
2 +$3.99M
3 +$1.99M
4
Vanguard Group
Vanguard Group
Pennsylvania
+$1.73M
5
Two Sigma Advisers
Two Sigma Advisers
New York
+$986K
Name Holding Trade Value Shares
Change
Change in
Stake
51
$236K
52
$233K
53
$232K
54
$230K
55
$230K
56
$223K
57
$222K
58
$221K
59
$221K
60
$213K
61
$202K
62
$195K
63
$187K
64
$180K
65
$177K
66
$167K
67
$167K
68
$161K
69
$157K
70
$157K
71
$151K
72
$150K
73
$125K
74
$123K
75
$121K